Latest Milan News

Vection Technologies has secured $1.5 million in AI-driven enterprise orders spanning agritech, cybersecurity, real estate, healthcare, and public administration, reinforcing its recurring revenue model and cross-sector appeal.

Syntara Limited is set to reveal fresh interim results from its Phase 2 trial of SNT-5505, targeting myelofibrosis, during an investor webinar ahead of a major European hematology conference.

Vection Technologies has successfully raised $3.55 million, exceeding its initial $2 million target, following a robust Q3 FY25 performance marked by a 92% increase in cash receipts and a significant boost in recurring revenue.

Vection Technologies has secured a three-year, AUD$575k partnership with global insurer Generali to deploy AI-driven extended reality solutions enhancing workplace safety and client engagement.

Vmoto reports a 33% decline in FY24 unit sales but maintains operational cash flow positivity and secures new joint ventures in Thailand and Mexico to bolster its electric mobility footprint.

OncoSil Medical has secured new distribution agreements across key international markets and achieved critical regulatory milestones, while raising $8 million to fuel its growth in pancreatic cancer treatment.